Glycated Albumin Market
- 2026 年市場規模
- USD 133.9 Mn
- 2033 年預估規模
- USD 234.6 Mn
- 年複合成長率 CAGR
- 8.5%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Glycated Albumin Market, By Product Type (Human Glycated Albumin, Animal Glycated Albumin), By Application (Diagnosis (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), Research), By End User (Hospitals/Clinics, Diagnostic Centers, Research Institutes, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Glycated albumin refers to albumin that are bonded to glucose. Albumin is present in blood and body fluids organs, and functions to maintain the shape of cell and helps in the distribution of hormones, nutrients, and some drugs in the body. Glycated albumin has been described as novel biomarkers for the detection and management of diabetes. It has also gained importance in glycemic monitoring for diabetes mellitus over the past few decades.
Market Dynamics
Increasing approval of novel glycated albumin products by key players in the market is expected to drive global glycated albumin kits/assays market growth in the near future. For instance, in 2017, the U.S. Food and Drug Administration (FDA) granted 510(k) clearance to Japan-based Asahi Kasei Pharma Corporation for its new Lucica Glycated Albumin-L, an in vitro diagnostic assay kit for glycated albumin (GA-L).
Furthermore, increasing prevalence of diabetes is expected to increase the demand for glycated albumin products, which can be used for the diagnosis/ detection of different types of diabetes such as type 1, and type 2 diabetes. For instance, according to the data published by the American Diabetes Associations in 2015, diabetes is the 7th leading cause of death in the U.S., where around 30.3 million people in the U.S. are suffering from diabetes. Among these, around 193,000 people in the U.S. below the age of 20 are suffering from diabetes.
Key features of the study
• This report provides in-depth analysis of glycated albumin market and provides market size (US$ Million) and cumulative annual growth rate (CAGR %) for the forecast period (2026 – 2033), considering 2025 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
• It profiles leading players in the global glycated albumin market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
• Key companies covered as a part of this study include Lifespan Biosciences, Biomatik Corporation, Abbexa Ltd., G Biosciences, DRG International, Inc., Amsbio LLC, Signalway Antibody LLC, United States Biological, Diazyme Laboratories, Abnova Corporation, Maccura Biotechnology Co. Ltd., Exocell Inc., Biorbyt Ltd., and Epinex Diagnostics Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The global glycated albumin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the glycated albumin market
Market Segmentation
• By Product Type (Revenue, USD Mn, 2021-2033)
o Human Glycated Albumin
o Animal Glycated Albumin
• By Application (Revenue, USD Mn, 2021-2033)
o Diagnosis
Prediabetes
Type 1 Diabetes
Type 2 Diabetes
o Research
• By End User (Revenue, USD Mn, 2021-2033)
o Hospitals/Clinics
o Diagnostic Centers
o Research Institutes
o Others
• By Region (Revenue, USD Mn, 2021-2033)
o North America
U.S.
Canada
o Latin America
Brazil
Mexico
Argentina
Rest of Latin America
o Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC
Israel
Rest of Middle East
o Africa
South Africa
Central Africa
North Africa
• Key Players
o Lifespan Biosciences
o Biomatik Corporation
o Abbexa Ltd.
o G Biosciences
o DRG International, Inc.
o Amsbio LLC
o Signalway Antibody LLC
o United States Biological
o Diazyme Laboratories,
o Abnova Corporation
o Maccura Biotechnology Co. Ltd.
o Exocell Inc.
o Biorbyt Ltd.
o Epinex Diagnostics Inc.
目錄 Table of Contents
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Product Type
Market Snippet, By Application
Market Snippet, By End User
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Product Launch
o Importance of Glycated Albumin
o Regulatory Scenario
o PEST Analysis
o Porter’s Five Forces Analysis
4. Global Glycated Albumin Market, By Product Type, 2021 – 2033 (US$ Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends
o Human Glycated Albumin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
Segment Trends
o Animal Glycated Albumin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
5. Global Glycated Albumin Market, By Application, 2021 – 2033 (US$ Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends
o Diagnosis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
Segment Trends
o Prediabetes
o Type 1 Diabetes
o Type 2 Diabetes
o Research
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
6. Global Glycated Albumin Market, By End User, 2021 – 2033 (US$ Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends
o Hospitals/Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
o Diagnostic Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
o Research Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Mn)
7. Global Glycated Albumin Market, By Region, 2021 – 2033 (US$ Mn)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2022–2033
o North America
Market Size and Forecast, By Product Type, 2021 – 2033 (US$ Mn)
Market Size and Forecast, By Application, 2021 – 2033 (US$ Mn)
Market Size and Forecast, By End User, 2021 – 2033 (US$ Mn)
Market Size and Forecast, By Country, 2021 – 2033 (US$ Mn)
o U.S.
o Canada
o Europe
Market Size and Forecast, By Product Type, 2021 – 2033 (US$ Mn)
Market Size and Forecast, By End User, 2021 – 2033 (US$ Mn)
Market Size and Forecast, By Country, 2021 – 2033 (US$ Mn)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Product Type, 2021 – 2033 (US$ Mn)
Market Size and Forecast, By Application, 2021 – 2033 (US$ Mn)
Market Size and Forecast, By End User, 2021 – 2033 (US$ Mn)
Market Size and Forecast, By Country, 2021 – 2033 (US$ Mn)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of APAC
o Latin America
Market Size and Forecast, By Product Type, 2021 – 2033 (US$ Mn)
Market Size and Forecast, By Application, 2021 – 2033 (US$ Mn)
Market Size and Forecast, By End User, 2021 – 2033 (US$ Mn)
Market Size and Forecast, By Country, 2021 – 2033 (US$ Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Africa
Market Size and Forecast, By Product Type, 2021 – 2033 (US$ Mn)
Market Size and Forecast, By Application, 2021 – 2033 (US$ Mn)
Market Size and Forecast, By End User, 2021 – 2033 (US$ Mn)
Market Size and Forecast, By Country, 2021 – 2033 (US$ Mn)
o Central Africa
o South Africa
o North Africa
o Middle East
Market Size and Forecast, By Product Type, 2021 – 2033 (US$ Mn)
Market Size and Forecast, By Application, 2021 – 2033 (US$ Mn)
Market Size and Forecast, By End User, 2021 – 2033 (US$ Mn)
Market Size and Forecast, By Country, 2021 – 2033 (US$ Mn)
o GCC
o Israel
o Rest of Middle East
8. Competitive Landscape
o Heat Map Analysis
o Company Profiles
Epinex Diagnostics Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Lifespan Biosciences
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Biomatik Corporation
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Abbexa Ltd.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
G Biosciences
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
DRG International, Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Amsbio LLC
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Signalway Antibody LLC
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
United States Biological
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Diazyme Laboratories
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Abnova Corporation
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Maccura Biotechnology Co. Ltd.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Exocell Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Biorbyt Ltd.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Epinex Diagnostics Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
9. Section
o References
o Research Methodology
o About us and Sales Contact
Browse 35 market data tables and 32 figures on “Glycated Albumin Market - Global forecast to 2033”.
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們